SIRT1 and liver dysplastic nodule: These findings indicate that targeting the SIRT1/NAD+ pathway not only alleviates oxidative stress but also improves metabolic disturbances by regulating downstream transcription factors including PGC-1α and FOXO, offering novel therapeutic avenues for DN.